DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/zz7xtq/glucocorticoidind) has announced the addition of the "Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014" report to their offering.
Our clinical trial report, Glucocorticoid-Induced Osteoporosis Global Clinical Trials Review, H1, 2014" provides data on the Glucocorticoid-Induced Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucocorticoid-Induced Osteoporosis.
It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucocorticoid-Induced Osteoporosis.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/zz7xtq/glucocorticoidind.
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Source: Research and Markets